Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Biliary Tract Adenocarcinoma × HMPL-013 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 53 Stomach Neoplasms 12 Colonic Neoplasms 7 Rectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 2 Sarcoma 2 Neoplasms 2 Neoplasm Metastasis 2 NSCLC 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Advanced Solid Tumors 2 Advanced Colorectal Carcinoma 2 Unresectable Metastatic Colorectal Cancer 1 To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma 1 TAS 102 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Patients With Advanced Metastatic Colorectal Cancer 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasm, Residual 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Metastatic Colorectal Adenocarcinoma 1 Metastasis Colorectal Cancer 1 MSS Metastatic Colorectal Cancer 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

toripalimab 1 donafenib 1 Oxaliplatin 1 HMPL-013 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04156958 2019-11-08

FSTAMBTA

Sichuan University

Phase 2 Unknown

Gastrointestinal

Biliary Tract Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡